NASDAQ:CABA
Cabaletta Bio, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.cabalettabio.comcrunchbase
cabaletta-biolinkedin
cabalettabiofounding date
Jun 01, 2017ipo date
Oct 25, 2019
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed t...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus